Investment objective & strategy
As of Dec. 18, 2025 · prospectusObjective. The Invesco NASDAQ Future Gen 200 ETF (the Fund) seeks to track the investment results (before fees and expenses) of the Nasdaq Innovators Completion Cap Index (the Underlying Index).
Strategy. The Fund generally will invest at least 90% of its total assets in the securities that comprise the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq, Inc. (Nasdaq or the Index Provider) compiles, maintains and calculates the Underlying Index, which is comprised of securities of approximately 200 Nasdaq-listed, non-financial companies outside of the Nasdaq-100 Index and Nasdaq Next Generation 100 Index that have the most valuable portfolios of patents relative to their total market values, as estimated by a third-party data provider. Securities are selected for inclusion in the Underlying Index based on the estimated value of their issuers patent portfolios, as determined by IPR Strategies, an independent data provider. IPR Strategies seeks to determine the … The Fund generally will invest at least 90% of its total assets in the securities that comprise the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq, Inc. (Nasdaq or the Index Provider) compiles, maintains and calculates the Underlying Index, which is comprised of securities of approximately 200 Nasdaq-listed, non-financial companies outside of the Nasdaq-100 Index and Nasdaq Next Generation 100 Index that have the most valuable portfolios of patents relative to their total market values, as estimated by a third-party data provider. Securities are selected for inclusion in the Underlying Index based on the estimated value of their issuers patent portfolios, as determined by IPR Strategies, an independent data provider. IPR Strategies seeks to determine the potential value of an issuer by quantifying such issuer's intangible assets, such as its intellectual property and research and development activities, as represented by patents held by such issuer. To value a companys patent portfolio, IPR Strategies utilizes a proprietary valuation model that takes into account patent data collected from multiple sources, including patent offices and corporate filings, as well as a variety of other economic data, including actual values from previously traded patents. The model then determines a patent value estimate, which represents the estimated dollar value of the portfolio of patents held by an issuer. To be eligible for inclusion in the Underlying Index, a security must be a member of the Nasdaq Composite Index (a broad-based, capitalization-weighted index of all stocks listed on the Nasdaq) and must, among other criteria at the time of screening, have (i) traded for at least three calendar months on the Nasdaq Stock Market, New York Stock Exchange, NYSE American or Cboe BZX Exchange, (ii) a minimum full market capitalization of $100 million, and (iii) a minimum three-month average daily trading value of $1 million. The Underlying Index excludes securities of issuers included in the Nasdaq-100 Index (an index that measures the performance of 100 of the largest Nasdaq-listed non-financial companies by market capitalization) and the Nasdaq Next Generation 100 Index (an index that measures the performance of the 100 largest Nasdaq-listed companies outside of the Nasdaq-100 Index based on market capitalization). Securities eligible for inclusion in the Underlying Index may be of any capitalization (subject to the minimum $100 million threshold noted above), including small- and mid-cap companies. Security types generally eligible for inclusion in the Underlying Index include common stocks and American Depositary Receipts (ADRs) that represent securities of non-U.S. issuers. The Underlying Index may include companies from all major sectors, except for companies that are classified as financials according to the Industry Classification Benchmark (ICB). All eligible issuers are ranked by the ratio of the companys patent value estimate (as determined by IPR Strategies) to its market capitalization, and the securities of the 200 issuers with the largest ratios (i.e., those with larger patent portfolio values relative to their market capitalization) are included in the Underlying Index. The Underlying Index is an equally weighted index. Equal weighting means that the Underlying Index assigns each component security the same weight. As of October 31, 2025, the Underlying Index was comprised of 198 constituents with market capitalizations ranging from $100.1 million to $18.5 billion. The Fund employs a full replication methodology in seeking to track the Underlying Index, meaning that the Fund generally invests in all of the securities comprising the Underlying Index in proportion to their weightings in the Underlying Index. Concentration Policy. The Fund will concentrate its investments (i.e., invest more than 25% of the value of its net assets) in securities of issuers in any one industry or group of industries only to the extent that the Underlying Index reflects a concentration in that industry or group of industries. The Fund will not otherwise concentrate its investments in securities of issuers in any one industry or group of industries. As of August 31, 2025, the Fund had significant exposure to the health care and information technology sectors. The Fund's portfolio holdings, and the extent to which it concentrates its investments, are likely to change over time.
Top holdings
As of Feb. 28, 2026 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| Invesco Private Prime Fund | — | $3.20M | 22.76% |
| Invesco Private Government Fund | — | $1.23M | 8.76% |
| AXT INC | — | $234.34K | 1.67% |
| INNOVATIVE SOLUT and SUPP INC | — | $176.21K | 1.25% |
| ALLOGENE THERAPEUTICS INC | — | $126.23K | 0.90% |
| NEOGEN CORP | — | $124.24K | 0.88% |
| SHATTUCK LABS INC | — | $123.61K | 0.88% |
| ALECTOR INC | — | $120.93K | 0.86% |
| ENTEGRIS INC | — | $113.64K | 0.81% |
| VANDA PHARMACEUTICALS INC | — | $110.06K | 0.78% |
Portfolio moves
Nov 30, 2025 → Feb 28, 2026How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| Invesco S&P SmallCap Health Care ETF · PSCH | 28% | 0.29% |
| Invesco Dorsey Wright SmallCap Momentum ETF · DWAS | 28% | 0.60% |
| Invesco Russell 2000 Dynamic Multifactor ETF · OMFS | 28% | 0.39% |
Advisers
| Firm | Role |
|---|---|
| Invesco Capital Management LLC | Adviser |
Footnotes
- Expense ratio as of December 18, 2025, from the fund's prospectus.
- Net assets and holdings count as of February 28, 2026, from the fund's N-PORT filing.
- Total return for calendar year 2025, before tax and after fund expenses. Computed by compounding the twelve monthly total returns the fund reported in its SEC N-PORT filings for 2025 (the latest prospectus does not yet chart this year).
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.